GleamWall
中文EN

FTLF FITLIFE BRANDS, INC.

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1374328 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY46.5%
TTM net income YoY1.9%
TTM EPS YoY1.5%
Revenue 3-yr CAGR32.2%
Net income 3-yr CAGR17.1%

Margins

Gross margin36.7%
Operating margin11.0%
Net margin6.7%
FCF margin4.5%
EBITDA margin11.9%

Returns

ROE15.1%
ROA6.4%
ROIC (approx.)13.8%
Asset turnover0.96x

Leverage & solvency

Liabilities / assets53.3%
Debt / equity0.00x
Current ratio1.64x
Interest coverage3.93x

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio2.0%
Payout ratio—
Capex / revenue0.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$81.46M$64.47M
Cost of revenue$50.01M$36.39M
Gross profit$31.45M$28.08M
SG&A expense$14.04M$9.97M
Operating income$10.06M$13.12M
Interest expense$1.86M$1.37M
Pretax income$8.23M$11.87M
Income tax$1.90M$2.89M
Net income$6.33M$8.98M
EBITDA$10.48M$13.23M
EPS (basic)0.680.98
EPS (diluted)0.630.91
Weighted avg. shares (diluted)9.98M9.90M
Balance sheet
Cash & equivalents$1.65M$4.47M
Receivables$8.77M$1.63M
Inventory$21.32M$11.07M
Current assets$33.07M$18.14M
PP&E, net$128,000$75,000
Goodwill$19.39M$13.02M
Intangibles$51.44M$26.23M
Total assets$106.32M$58.53M
Current liabilities$21.61M$11.31M
Short-term debt—$4.50M
Long-term debt—$8.55M
Total debt—$13.05M
Total liabilities$62.68M$22.41M
Shareholders' equity$43.64M$36.13M
Net debt—$8.58M
Shares outstanding9.39M9.21M
Cash flow statement
Operating cash flow$7.44M$9.61M
Capital expenditure$42,000$10,000
Free cash flow$7.40M$9.60M
Investing cash flow-$42.54M-$10,000
Financing cash flow$32.09M-$6.98M
Depreciation & amortization$420,000$108,000

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.